SCHEMBL25975348

SCHEMBL25975348

CNC(=O)C1(c2ccc(C)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
HTR1E P28566 1/20 0.48
S1PR3 Q99500 1/20 0.48
LMNA P02545 2/20 0.48
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C9 P11712 2/20 0.42
HSD11B1 P28845 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
HDAC4 P56524 4/20 0.42
OPRM1 P35372 1/20 0.42
OPRL1 P41146 1/20 0.42
PKM P14618 1/20 0.40
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
P2RX7 Q99572 1/20 0.39
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4711347 0.85 HDAC4 (0.42) LMNACYP2C9HSD11B1CYP3A4CYP2D6
SCHEMBL3553242 0.83 HDAC4 (0.62) NPSR1LMNAKDM4EHSD11B1HDAC4
SCHEMBL8572144 0.82 HDAC4 (0.59) NPSR1LMNAHSD11B1HDAC4OPRL1
SCHEMBL4711696 0.80 ALDH1A1 (0.59) MAPTNPSR1LMNAKDM4EHPGD
SCHEMBL19537445 0.79 LMNA (0.50) NPSR1LMNAHSD11B1HDAC4OPRL1
SCHEMBL351393 0.78 AKR1C1 (0.55) LMNACYP2C9HSD11B1CYP3A4CYP2D6
SCHEMBL5379326 0.78 HSD11B1 (0.45) MAPTNPSR1HTR1ES1PR3LMNA
SCHEMBL22266637 0.78 LMNA (0.72) MAPTNPSR1HTR1ES1PR3LMNA
SCHEMBL844453 0.77 OPRM1 (0.53) MAPTNPSR1HTR1ES1PR3LMNA
SCHEMBL25460818 0.77 HDAC4 (0.73) MAPTNPSR1LMNAHSD11B1HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023154282-A1 COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS THERAS, INC. (US) 2023-08-17 WO disclosed